Tango drug combination shows 92% response rate in pancreatic cancer trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Tango drug combination shows 92% response rate in pancreatic cancer trial
(NASDAQ: TNGX) Delayed: 28.50 +0.53 (1.89%)
Previous Close $27.97    52 Week High $ 
Open $28.52    52 Week Low $ 
Day High $28.95    P/E N/A 
Day Low $28.01    EPS $ 
Volume 6,313,675